These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. A therapeutic dose of memantine improves the performance of rats in an active place avoidance task under the continuous dissociation of distal room and proximal arena cues. Wesierska M; Svoboda J; Stuchlik A Neurobiol Learn Mem; 2019 Jul; 162():59-66. PubMed ID: 31085330 [TBL] [Abstract][Full Text] [Related]
43. Enhancement of long-term spatial memory in adult rats by the noncompetitive NMDA receptor antagonists, memantine and neramexane. Zoladz PR; Campbell AM; Park CR; Schaefer D; Danysz W; Diamond DM Pharmacol Biochem Behav; 2006 Oct; 85(2):298-306. PubMed ID: 17045636 [TBL] [Abstract][Full Text] [Related]
44. NMDA receptor antagonists. A new therapeutic approach for Alzheimer's disease. Farlow MR Geriatrics; 2004 Jun; 59(6):22-7. PubMed ID: 15224791 [TBL] [Abstract][Full Text] [Related]
45. Memantine partly rescues behavioral and cognitive deficits in an animal model of neurodegeneration. Borre Y; Bosman E; Lemstra S; Westphal KG; Olivier B; Oosting RS Neuropharmacology; 2012 Apr; 62(5-6):2010-7. PubMed ID: 22248638 [TBL] [Abstract][Full Text] [Related]
46. Synergistic effects of antidementia drugs on spatial learning and recall in the APP23 transgenic mouse model of Alzheimer's disease. Neumeister KL; Riepe MW J Alzheimers Dis; 2012; 30(2):245-51. PubMed ID: 22414570 [TBL] [Abstract][Full Text] [Related]
47. [Memantine brakes Alzheimer's dementia. The NMDA antagonist is effective in severe cases, too]. MMW Fortschr Med; 2003 May; 145 Suppl 2():21. PubMed ID: 14579479 [No Abstract] [Full Text] [Related]
48. Does memantine improve memory in subjects with focal-onset epilepsy and memory dysfunction? A randomized, double-blind, placebo-controlled trial. Leeman-Markowski BA; Meador KJ; Moo LR; Cole AJ; Hoch DB; Garcia E; Schachter SC Epilepsy Behav; 2018 Nov; 88():315-324. PubMed ID: 30449328 [TBL] [Abstract][Full Text] [Related]
49. Cognitive evaluation of disease-modifying efficacy of galantamine and memantine in the APP23 model. Van Dam D; De Deyn PP Eur Neuropsychopharmacol; 2006 Jan; 16(1):59-69. PubMed ID: 16095884 [TBL] [Abstract][Full Text] [Related]
51. Delay-dependent impairment of a matching-to-place task with chronic and intrahippocampal infusion of the NMDA-antagonist D-AP5. Steele RJ; Morris RG Hippocampus; 1999; 9(2):118-36. PubMed ID: 10226773 [TBL] [Abstract][Full Text] [Related]
52. Effects of acute administration of donepezil or memantine on sleep-deprivation-induced spatial memory deficit in young and aged non-human primate grey mouse lemurs (Microcebus murinus). Rahman A; Lamberty Y; Schenker E; Cella M; Languille S; Bordet R; Richardson J; Pifferi F; Aujard F PLoS One; 2017; 12(9):e0184822. PubMed ID: 28922421 [TBL] [Abstract][Full Text] [Related]
53. The uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist memantine prolongs spatial memory in a rat delayed radial-arm maze memory task. Wise LE; Lichtman AH Eur J Pharmacol; 2007 Dec; 575(1-3):98-102. PubMed ID: 17850786 [TBL] [Abstract][Full Text] [Related]
54. Improvement of episodic contextual memory by S 18986 in middle-aged mice: comparison with donepezil. Béracochéa D; Philippin JN; Meunier S; Morain P; Bernard K Psychopharmacology (Berl); 2007 Jul; 193(1):63-73. PubMed ID: 17384936 [TBL] [Abstract][Full Text] [Related]